The New York Times reports that the FDA is now working under the assumption that the deadly contamination of heparin was intentional. In her prepared testimony before a congressional subcommittee, Janet Woodcock, director of the FDA’s Center for Drug Evaluation said,
FDA’s working hypothesis is that this was intentional contamination, but this has not been proven.
More details, inside…
